Who We Are

Leadership Team

  • Jesper Østergaard Jensen Chief Executive Officer and President

    Jesper brings to TruMed almost 20 years of progressive healthcare and medical device experience. Jesper has a track record of building successful teams in Sales, Marketing, Managed Care and Medical. Most recently he served as Executive Vice President and Business Unit head of Biologics and Dermatology at Sun Pharma Industries (BOM: 524715). Jesper’s experiences include Global Commercial Leader at Amgen, Vice President of Endocrinology Sales and Marketing at Halozyme Therapeutics (Nasdaq: HALO), and various roles of increasing responsibility at Novo Nordisk (NYSE: NVO), Boehringer Ingelheim, and McKinsey & Company.

  • Eugene A. Baker Founder

    Gene brings to TruMed more than 25 years of healthcare, supply chain, and start-up experience. Most recently, Gene served as VP of Strategy and Business Innovation, Dispensing (Pyxis), for CareFusion (NYSE: CFN), a leader in hospital medication dispensing and supply management systems. Gene's start-up experiences include Nature's Cure, OmniCell Technologies (Nasdaq: OMCL), HeartScan Imaging, and Hudson Bend Corp., among others. When he is not working on technology and business innovation and growth, you can probably find Gene coaching or watching youth soccer or umpiring Little League baseball in the Bay Area. Gene is a licensed Professional Engineer and earned a Master of Business Administration from Stanford University and a Bachelor of Science degree from the US Military Academy.

  • Thomas M. Netzer General Manager, Vaccine Systems

    Tom comes to TruMed with more than 25 years of experience working in the vaccines and small-molecule pharmaceuticals industry, including nearly two decades working in Global Enterprise Leadership and Product Launch roles at Merck. Earlier in his career, Tom held various product manager and business development positions at Wyeth-Lederle Vaccines & Pediatrics and Lederle Laboratories. He earned a Master of Business Administration with honors, at the Fox School of Business and Management, Temple University and served as a Commissioned Officer in the US Army, earning numerous awards, including the Bronze Star Medal.

  • Joe Milkovits Chief Technical Officer and Vice President of Engineering

    Joe comes to TruMed with over 25 years of experience in R&D, Engineering, Product Design & Manufacturing Management. He has held senior technical positions at HP, Kodak & multiple start ups. Earlier in his career, Joe was awarded several US Patents for printer design. He has Bachelor & Master's degrees in Mechanical Engineering from the University of Michigan, Ann Arbor.

  • Jim Martindale Vice President of Field Operations

    Jim brings over 25 years of technology, operational, and service delivery leadership to TruMed. He has a successful track record of building successful organizations both inside fortune 500 companies as well as ground floor start-ups. Prior to joining TruMed, Jim was President & CEO of ADTI Media, an LED Display start-up with successful deployments in New York’s Times Square, Dubai, Argentina, Australia, and across the USA. His experience also includes key leadership positions at InFocus Corporation, and Hewlett-Packard.

Board of Directors

  • David J. Williams

    Over the course of his 30-year career, Mr. Williams played a vital role in growing Sanofi Pasteur into the world`s largest vaccine company. He served as Chairman and CEO of Sanofi Pasteur, S.A., the vaccines business of Sanofi-Aventis. During his tenure, the organization grew from 100 employees and sales of just over $5 million to 11,000 employees and more than $6 billion in revenue. He was chairman of the company's board of directors and a member of the Supervisory Board of Sanofi Pasteur MSD, a 50-50 joint venture with Merck & Co. Early in his career, Dave spent more than five years at PricewaterhouseCoopers in their Audit and Healthcare Consulting Group.

  • Michael de Anda

    Mr. de Anda is the founder of de Anda Capital LLC, a Bay area based family office. He has over twenty years experience investing in growth companies. He currently serves on the boards of Lecorpio, Veri-tax, Therapydia and PRE Diversified Holdings. Mr. de Anda earned his C.P.A. in Illinois. He holds a Bachelors degree in Accounting from DePaul University and a Master of Business Administration from Stanford University's Graduate School of Business.

  • Eugene A. Baker

    Gene brings to TruMed more than 25 years of healthcare, supply chain, and start-up experience. Most recently, Gene served as VP of Strategy and Business Innovation, Dispensing (Pyxis), for CareFusion (NYSE: CFN), a leader in hospital medication dispensing and supply management systems. Gene's start-up experiences include Nature's Cure, OmniCell Technologies (Nasdaq: OMCL), HeartScan Imaging, and Hudson Bend Corp., among others. When he is not working on technology and business innovation and growth, you can probably find Gene coaching or watching youth soccer or umpiring Little League baseball in the Bay Area. Gene is a licensed Professional Engineer and earned a Master of Business Administration from Stanford University and a Bachelor of Science degree from the US Military Academy.

  • Michael O'Connell

    Michael F. O'Connell is the head Managing Director at M2O, Inc. He oversees the assessment of investment opportunities and reviews the ongoing performance of portfolio companies. Michael also sits on the board of American Biosurgical, Inc. For the bulk of his career, Michael was the Managing Director and President of Anhalt, O'Connell & Steffanci Inc., a Los Angeles-based investment management firm with almost $1 billion under management. In 1992, Michael purchased the National Lines Bureau, a ship mooring company operating in the Los Angeles and Long Beach harbors, the largest commercial port in America. That initial investment spawned several others and Michael soon shifted his focus from investment management to venture capital. Today, he leads M2O with a portfolio of more than 30 companies. Michael holds a B.A., with high honors, from Harvard College and an MBA from Harvard Business School.

  • Jesper Østergaard Jensen

    Jesper serves as Chief Executive Officer and President of Trumed Systems, Inc. Most recently he was Executive Vice President and Business Unit head of Biologics and Dermatology at Sun Pharma Industries (BOM: 524715) and was a member of the Company’s Executive Management Team. Jesper earned his Master of Business Administration from the Wharton School of Business at the University of Pennsylvania where he was a Palmer Scholar, has a Master of Science in Engineering from the Danish Technical University, and graduated with Bachelors of Science in Physics and in Economics from Massachusetts Institute of Technology.